Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive african health registry aims to tackle rising chronic diseases

NCT ID NCT03473795

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 19, 2026 · Updated 3 times

Summary

This study is creating large registries for non-communicable diseases (like cancer and diabetes) in sub-Saharan Africa. Researchers will collect health data, questionnaires, and biological samples from nearly 7,000 adults, including healthy volunteers for comparison. The goal is to gather accurate information to better understand these diseases and improve patient outcomes in the region.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide high-quality data to better understand and manage non-communicable diseases in Africa, potentially improving patient care and outcomes.
What could go wrong
This is an observational registry study, not a treatment trial. It may not directly lead to new therapies, and data quality depends on participant reporting and follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

6,990 people

The number who actually took part.

Started

Mar 2018

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be accrued in medical clinics in Africa as determined by the local investigators and local research staff.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 and older. * Suspected or confirmed diagnosis of a non-communicable disease. OR * Healthy volunteers/no confirmed diagnosis for comparison. Exclusion Criteria: * Participants unwilling to sign consent. * Participants under the age of 18

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-communicable disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Noncommunicable Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Federal Medical Centre Owo

    Owo, Ondo State, Nigeria

  • Federal Medical Centre Owo

    Owo, Nigeria

  • Ladoke Akintola University of Technology

    Ogbomoso, Oyo State, Nigeria

  • Lagos State University Teaching Hospital

    Idi-Araba, Lagos, Nigeria

  • Lagos State University Teaching Hospital

    Ikeja, Nigeria

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • National Hospital of Abuja (Data collection only)

    Abuja, Central Business District, 900103, Nigeria

  • Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC)

    Ile-Ife, Nigeria

  • Olabisis Onabanjo University Teaching Hospital

    Sagamu, Ogun State, Nigeria

  • Ondo State Trauma and Surgical Centre

    Ondo, Nigeria

  • University College Hospital

    Ibadan, Oyo State, Nigeria

  • University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu

    Enugu, Nigeria

  • University of Ilorin Teaching Hospitals

    Ilorin, Nigeria

  • University of Maiduguri Teaching Hospital (Data collection only)

    Maiduguri, 600104, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.